Representative before the EPO

Employment test 501 - 1000 employees
Company dna marks and clerk llp
operating since 1887
1382.89
Headquarter in London and 20 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

We have observed 141 EP applications Paul Gilmour Chapman has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11785753

NOVEL LARGE PORE METAL ORGANIC FRAMEWORKS

IPC classification:
B01J 31/18, B01J 31/16, B01J 20/22
Applicant:
The University Court of the University of St. Andrews
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION IN PROGRESS
EP11834936

AUTOMATIC MONITORING OF INSECT POPULATIONS

IPC classification:
A01M 1/12, A01M 1/14, A01M 1/04
Applicant:
Purdue Research Foundation (PRF)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP11853508

TWO-PART CURABLE OXYGEN-ABSORBABLE RESIN COMPOSITION, AND OXYGEN-ABSORBABLE ADHESIVE AGENT

IPC classification:
C08G 63/553, C09J 167/06, C09J 175/06, C08G 18/42
Applicant:
Toyo Seikan Group Holdings Ltd (Toyo Seikan Kaisha Ltd)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP12709137

MICROFLUIDICS BASED ASSAY DEVICE

IPC classification:
G01N 33/543
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The patent has been granted
EP12713248

PESTICIDES

IPC classification:
A01N 63/00, C07K 14/47, C07K 14/435
Applicant:
University of Durham
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP12777657

MODIFIED SENDAI VIRUS VACCINE AND IMAGING VECTOR

IPC classification:
A61K 39/155, C12N 15/86, C12N 7/01
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP12802495

AMPLIFICATION ENHANCEMENT OF BLOOD DERIVED PROGENITOR CELLS USING A CLOSED CULTURE SYSTEM

IPC classification:
C12N 5/02, C12N 5/00
Applicant:
University Hospitals Cleveland Medical Center
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12730232

GROWTH OF CELLS

IPC classification:
C12N 5/00
Applicant:
University of Edinburgh
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12730505

RELAXIN PROTEINS FOR USE IN THE DIAGNOSIS, PREVENTION OR TREATMENT OF MULTIPLE SCLEROSIS

IPC classification:
A61K 38/22
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The patent has been granted
EP12753163

INHIBITORS AGAINST ENDOSOMAL/LYSOSOMAL ENZYMES

IPC classification:
A61K 38/57, C07K 14/81
Applicant:
University of Dundee
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
PATENT GRANTED
EP11872018

COMPOSITIONS AND METHODS FOR DETECTING AUTOANTIBODIES

IPC classification:
G01N 33/53
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The patent has been granted
EP12773108

TARGETING OF MIRNA PRECURSORS

IPC classification:
A61K 31/7088, C12N 15/113
Applicant:
University of Dundee
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14157639

Refrigerator-temperature stable influenza vaccine compositions

IPC classification:
A61K 39/145, C12N 7/02
Applicant:
MedImmune, LLC
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
PATENT GRANTED
EP12771026

OSTEOBLAST-EXPRESSED LIPOCALIN 2 REGULATES GLUCOSE METABOLISM

IPC classification:
A61K 38/17, A61P 19/10, A61P 19/00, A61P 3/08, A61P 3/04
Applicant:
Columbia University in the City of New York
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12770596

NANOMEDICINES FOR EARLY NERVE REPAIR

IPC classification:
A61K 47/48, A61K 36/9066, A61K 9/51, A61K 9/26, A61K 9/19, A61K 9/00, A61P 25/00
Applicant:
Purdue Research Foundation (PRF)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13184442

Packaging material and package structure using the same

IPC classification:
A61K 9/70, B32B 27/40, B32B 27/36, B32B 27/30, B32B 27/08, B32B 15/095, B32B 15/082, B32B 7/12
Applicant:
Toyo Seikan Group Holdings Ltd (Toyo Seikan Kaisha Ltd)
Applicant:
Nitto Denko Corporation
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP12801911

PROCESS AND APPARATUS FOR CONTINUOUS PRODUCTION OF DENSIFIED CHARCOAL

IPC classification:
C10B 53/02, C10B 49/02, C10B 37/04, C10B 1/04
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION IN PROGRESS
EP14166270

Evaluating viral receptor/coreceptor usage

IPC classification:
C12Q 1/70
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
PATENT GRANTED
EP14151932

Monoclonal antibodies binding canine CD20

IPC classification:
A61K 45/06, A61K 39/395, C07K 16/28
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13746815

SURFACE

IPC classification:
C23C 8/24, C23C 8/20, B41N 1/16, B41M 99/00, B05C 21/00
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13747268

REDUCING FRICTION OF A VISCOUS FLUID FLOW IN A CONDUIT

IPC classification:
F17D 1/16
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13755368

TARGETED TREATMENT OF ANEROBIC CANCER

IPC classification:
A61K 49/06
Applicant:
University Hospitals Cleveland Medical Center
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP13711103

A SIK INHIBITOR FOR USE IN A METHOD OF TREATING AN INFLAMMATORY AND/OR IMMUNE DISORDER

IPC classification:
A61K 31/5377, A61K 31/519, A61K 31/506, A61K 31/00, A61P 29/00
Applicant:
University Court of The University of Dundee
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION IN PROGRESS
EP14163419

Vestibular stimulation apparatus and associated methods of use

IPC classification:
A61H 39/06, A61F 7/00, A61B 5/01, A61N 1/36
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13769101

4 AMINOPYRIDINE AS A THERAPEUTIC AGENT FOR SPINAL MUSCULAR ATROPHY

IPC classification:
A61K 31/4409
Applicant:
Columbia University in the City of New York
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13772931

A PROCESS FOR PRODUCING A TITANIUM LOAD-BEARING STRUCTURE

IPC classification:
C23C 30/00, C23C 24/08, C23C 4/12, B05D 7/14, B05D 1/12, B05C 5/00, B05B 7/16
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION IN PROGRESS
EP13718358

PARKINSON'S DISEASE BIOMARKER

IPC classification:
G01N 33/68
Applicant:
University of Dundee - Research and Innovation Services
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13776189

NOVEL METHODS

IPC classification:
A61K 31/4985
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP12802033

APPARATUS AND PROCESS FOR CONTINUOUS CARBONISATION OF WOOD CHIPS OR WASTES AND OTHER CHARRING ORGANIC MATERIALS

IPC classification:
C10B 53/02, C10B 49/02, C10B 1/04
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13781248

THERAPEUTIC PILLOW

IPC classification:
A61G 7/07, A61F 5/37, A47G 9/10
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The patent has been granted
EP13784513

ANTIPROLIFERATIVE SURFACE MODIFICATIONS AND METHODS OF USE

IPC classification:
A61L 31/16
Applicant:
The Regents of the University of Colorado
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP13729797

GENETICALLY MODIFIED SCHMALLENBERG VIRUS (SBV) FOR USE AS VACCINE

IPC classification:
A61K 39/12, A01K 67/027, C12N 7/00
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13730305

SYNTHESIS OF MOFS

IPC classification:
A01N 25/10, C07F 15/04, C07F 3/06, C07F 1/10
Applicant:
The University Court of the University of St. Andrews
Agent:
Multiple attorneys, Marks & Clerk
Status:
The patent has been granted
EP13812533

QUANTITATIVE ASSESSMENT OF HUMAN T-CELL REPERTOIRE RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

IPC classification:
C12Q 1/68, C07K 14/725
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13823262

TECHNIQUES FOR EMERGENCY APNEIC OXYGENATION

IPC classification:
A61M 25/088, A61M 25/01, A61M 16/04
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP12739834

URINE BIOMARKERS FOR PREDICTION OF RECOVERY AFTER ACUTE KIDNEY INJURY : PROTEOMICS

IPC classification:
G01N 33/68, A61M 1/14, G01N 33/53, G01N 33/50
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION IN PROGRESS
EP13742710

IMMUNOMODULATORY COMPOUNDS

IPC classification:
A61K 31/10, C07D 295/088, C07C 317/28, A61P 29/00
Applicant:
University of Glasgow
Applicant:
University of Strathclyde
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION IN PROGRESS
EP13828566

INJECTABLE BROWN ADIPOSE MICROTISSUES FOR TREATMENT AND PREVENTION OF OBESITY AND DIABETES

IPC classification:
C12N 5/0775, C12N 5/074, A61P 3/04
Applicant:
Columbia University in the City of New York
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13829362

DIAGNOSTIC MARKERS OF INDOLENT PROSTATE CANCER

IPC classification:
G01N 33/00, C12Q 1/68
Applicant:
Columbia University in the City of New York
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13830257

FORMATION, REPAIR AND MODIFICATION OF LAY UP TOOLS

IPC classification:
C23C 24/04, B29C 70/30, B21K 5/20, B21D 37/02, B05B 13/00
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The patent has been granted
EP13830291

BLOOM RESISTANT FROZEN BAKERY PRODUCTS

IPC classification:
A23L 1/00, A21D 13/00
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13838231

PACKAGING MATERIAL AND PACKAGING STRUCTURE MADE BY USING SAME

IPC classification:
B65D 65/40, B32B 27/36
Applicant:
Toyo Seikan Group Holdings Ltd (Toyo Seikan Kaisha Ltd)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The patent has been granted
EP13855655

METHODS OF TREATMENT OF KERATINOCYTE-DERIVED LESIONS

IPC classification:
A61K 31/69, A61K 31/125
Applicant:
Columbia University in the City of New York
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13853653

TECHNIQUES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

IPC classification:
C12Q 1/68
Applicant:
Columbia University in the City of New York
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP15160407

MODIFIED PECTINS, COMPOSITIONS AND METHODS RELATED THERETO

IPC classification:
A61K 31/732
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15164924

COMPOSITIONS TO SUPPORT TISSUE INTEGRATION AND INOSCULATION OF TRANSPLANTED TISSUE AND TRANSPLANTED ENGINEERED PENILE TISSUE WITH ADIPOSE STROMAL CELLS

IPC classification:
A61K 35/48, A61K 35/44, A61K 35/33, A61K 35/28, A61K 35/12
Agent:
Paul Gilmour Chapman, Marks & Clerk
Agent:
Brevalex
Status:
GRANT OF PATENT INTENDED
EP13863737

BLOOM-RESISTANT BARRIER FOOD PACKAGING

IPC classification:
A23L 3/365, A23G 3/00, A21D 15/02
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14740945

OXYGEN-ABSORBING FILM, AND OXYGEN-ABSORBING ADHESIVE AGENT RESIN COMPOSITION

IPC classification:
C09J 201/00, C09J 175/04, C09J 167/00, C09J 11/06
Applicant:
Toyo Seikan Group Holdings Ltd (Toyo Seikan Kaisha Ltd)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14742995

TETRAZINES/TRANS-CYCLOOCTENES IN SOLID PHASE SYNTHESIS OF LABELED PEPTIDES

IPC classification:
A61M 36/14, A61K 51/00, C12P 21/08, C07K 16/00
Applicant:
Massachusetts General Hospital
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14743694

MOISTURE-RESISTANT EDIBLE FOOD COATING AND METHOD FOR APPLYING THE SAME

IPC classification:
A23F 5/00
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14746750

RESPIRATORY SYNCYTIAL VIRUS F PROTEIN EPITOPES

IPC classification:
A61P 31/14
Applicant:
MedImmune, LLC
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13837467

(ARGO)N-ANGIOTENSIN-(1-7) PEPTIDE AND PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES

IPC classification:
A61P 9/08, A61K 38/08, C07K 7/14
Applicant:
Federal University of Minas Gerais (Universidade Federal de Minas Gerais (UFMG))
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP13875064

INORGANIC PHOSPHATE CERAMICS AND COATINGS

IPC classification:
C04B 18/04, C04B 26/30, C04B 22/16
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP13875160

INORGANIC COATING AND COMPOSITION

IPC classification:
C23C 26/00, C23C 30/00
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14754815

USE OF AN OMEGA-3 LIPID-BASED EMULSION FOR PROTECTING HUMAN ORGANS FROM ISCHEMIC INJURY

IPC classification:
A61K 31/20
Applicant:
Columbia University in the City of New York
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14761174

CO-ADMINISTRATION OF STEROIDS AND ZOLEDRONIC ACID TO PREVENT AND TREAT OSTEOARTHRITIS

IPC classification:
A61P 19/02, A61K 31/663, A61K 31/12
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14762744

PRODUCTION OF ALUMINIUM-SCANDIUM ALLOYS

IPC classification:
C22B 21/02, C22B 5/04, C22C 1/04, C22C 1/02, C22C 21/00
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14769399

METHODS AND ALGORITHM FOR SELECTING ALLOGENIC HEMATOPOIETIC CELL DONOR BASED ON KIR AND HLA GENOTYPES

IPC classification:
G06Q 50/24
Agent:
Paul Gilmour Chapman, Marks & Clerk
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14769498

KIR3DL1 ALLELE CLASSIFICATION KIT AND METHOD

IPC classification:
C12N 15/11, C12Q 1/68
Agent:
Paul Gilmour Chapman, Marks & Clerk
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14768321

PURIFICATION OF TRIPLE HELICAL PROTEINS

IPC classification:
C07K 1/30, C07K 1/14
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14717171

CO-EXPRESSION OF FACTOR VIII AND VON WILLEBRAND FACTOR

IPC classification:
C12N 5/00
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The patent has been granted
EP14798247

ANALYTE ENRICHMENT METHODS AND COMPOSITIONS

IPC classification:
C12Q 1/68
Applicant:
Qiagen Sciences, LLC
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14804836

DEVICES AND METHODS FOR CREATING A PREDICTABLE CAPSULORHEXIS OF SPECIFIC DIAMETER

IPC classification:
A61F 9/007
Applicant:
The Regents of the University of Colorado
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14810233

PROCESS FOR PREPARING AMPHIPHILIC PEPTIDE DERIVATIVES

IPC classification:
A61P 17/14, A61P 15/10, A61P 27/06, A61P 21/00, A61P 3/00, A61P 9/00, A61K 31/215, A61K 38/08, A61K 38/00, C07K 7/14, C07K 1/113
Applicant:
Federal University of Minas Gerais (Universidade Federal de Minas Gerais (UFMG))
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14822812

MINIMAL PIGGYBAC VECTORS FOR GENOME INTEGRATION

IPC classification:
C12N 15/85
Applicant:
University of South Alabama
Agent:
Paul Gilmour Chapman, Marks & Clerk
Agent:
Cabinet Regimbeau
Status:
GRANT OF PATENT INTENDED
EP14826459

3B -HYDROXYSTEROID DEHYDROGENASE IN STEROID-DEPENDENT DISEASE

IPC classification:
G01N 33/574
Applicant:
The Cleveland Clinic Foundation
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14744868

CONFORMANCE CONTROL IN ENHANCED OIL RECOVERY

IPC classification:
C09K 8/58
Applicant:
Maersk Olie & Gas A/S
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION IN PROGRESS
EP14835769

METHOD AND APPARATUS FOR PREDICTING A NEED FOR A BLOOD TRANSFUSION

IPC classification:
A61B 5/00
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14836005

INORGANIC PHOSPHATE CORROSION RESISTANT COATINGS

IPC classification:
C23F 11/18, C23F 11/08, C23F 11/00
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP16157855

METHOD FOR PRODUCING OLIGOMER AND/OR MONOMER BY DEGRADING BIODEGRADABLE RESIN

IPC classification:
C08J 11/10, C08L 67/00, C12P 7/44, C12P 7/46, C12P 7/56, C12P 7/62
Applicant:
Toyo Seikan Group Holdings Ltd (Toyo Seikan Kaisha Ltd)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14849381

MANIFOLD DIFFUSION OF SOLUTIONS FOR KINETIC ANALYSIS OF PHARMACOKINETIC DATA

IPC classification:
G06F 19/26, G06T 7/00
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Gill Jennings & Every LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14850522

NANOPARTICLE BASED ARTIFICIAL ANTIGEN PRESENTING CELL MEDIATED ACTIVATION OF NKT CELLS

IPC classification:
A61K 47/30, A61K 39/395, A61K 47/48, A61K 9/16
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14853877

METHODS OF GENERATING MATURE HUMAN MUSCLE FIBERS

IPC classification:
A61P 21/00, A61K 35/12
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
GRANT OF PATENT INTENDED
EP14853310

PROCESS AND SYSTEM FOR HIGH SOLIDS FERMENTATION

IPC classification:
C12P 7/06
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14803000

DOSAGE FORM COMPRISING AN ACTIVE INGREDIENT AND A PLURALITY OF SOLID POROUS MICROCARRIERS

IPC classification:
A61P 31/04, A61K 31/65, A61K 9/50, A61K 9/16
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15190775

ANTIBODIES AGAINST AND METHODS FOR PRODUCING VACCINES FOR RESPIRATORY SYNCYTIAL VIRUS

IPC classification:
G01N 33/68, C12N 7/00, C07K 14/005, A61K 39/155, A61K 39/00, C07K 16/10, G01N 33/53
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
APPLICATION PUBLISHED
EP14861222

MICELLE-BASED DELIVERY OF DERMAL THERAPEUTIC MATERIALS

IPC classification:
A61K 9/06
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14802043

GLYCAN ANALYSIS BY DERIVATISING SIALIC ACID RESIDUES

IPC classification:
G01N 33/483, C08B 37/00
Applicant:
Leiden University Medical Center (Leids Universitair Medisch Centrum (LUMC) - Academisch Ziekenhuis Leiden)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP11784772

LIGHT INDUCED DRUG RELEASE

IPC classification:
A61K 33/24
Applicant:
Leiden University (Universiteit Leiden)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13802806

CANINE AUTOIMMUNE CONDITIONS AND DIAGNOSIS AND TREATMENT THEREOF

IPC classification:
C12Q 1/68
Applicant:
Hill's Pet Nutrition, Inc.
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The patent has been granted
EP14869581

COMPOSITIONS AND METHODS FOR TREATING DISEASE USING SALMONELLA T3SS EFFECTOR PROTEIN (SIPA)

IPC classification:
G01N 33/574
Applicant:
University of Massachusetts
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14821247

PESTICIDAL FUSION PROTEIN IMPROVEMENTS

IPC classification:
C07K 14/435
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION IN PROGRESS
EP13821384

HIGH NUTRIENT YEAST

IPC classification:
C12P 7/06, C12N 1/16, C12N 1/06, C12N 1/00, A23K 10/00, A23L 33/10
Applicant:
Hill's Pet Nutrition, Inc.
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14792932

CONTAINER WITH HEAT-SEALED COMPOSITE PLASTIC AND METAL SCREW CLOSURE

IPC classification:
B65D 41/04, B65D 53/04, B65D 51/14
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15735408

PRODUCTS AND PHARMACEUTICAL COMPOSITIONS

IPC classification:
C07D 487/04, A61P 25/16, A61K 31/519
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP16170327

FLEXIBLE LAMINATE STRUCTURE WITH INTEGRATED ONE-WAY VALVE

IPC classification:
B65D 90/34, B65D 33/01, B32B 3/26, B32B 27/36, B32B 27/32, B32B 7/12
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14879925

MOISTURE-RESISTANT EDIBLE FOOD COATING AND METHOD FOR APPLYING THE SAME

IPC classification:
A23L 3/00, A23L 5/00, A23G 3/54
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15740996

SYSTEM AND METHOD FOR EMERGENCY APNEIC OXYGENATION

IPC classification:
A61M 16/04
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP16187778

METHODS OF DIAGNOSING PROLIFERATIVE DISORDERS

IPC classification:
G01N 21/552, G01N 33/574
Applicant:
The University of Central Lancashire
Agent:
Paul Gilmour Chapman, Marks & Clerk
Agent:
Dr Mike Holmes, HGF Limited
Status:
Request for examination was made
EP15773589

ORGANIC COMPOUNDS

IPC classification:
C07D 471/14, A61K 31/4985
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15719819

COMPLIANT ACTUATOR

IPC classification:
G02B 23/24, A61B 1/00, F03G 7/06
Applicant:
University of Dundee
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15788911

SYNTHETIC THREAD BASED LATERAL FLOW IMMUNOASSAY

IPC classification:
G01N 33/53
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15726669

STABLE EMULSIONS

IPC classification:
A61K 9/107, A61K 38/06, A23L 29/10, A23L 33/17
Applicant:
University of Strathclyde
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15811242

INHIBITION OF SEROTONIN EXPRESSION IN GUT ENTEROENDOCRINE CELLS RESULTS IN CONVERSION TO INSULIN-POSITIVE CELLS

IPC classification:
C12N 15/113, A61K 39/395
Applicant:
Columbia University in the City of New York
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15824358

METHODS OF CONJUGATING AN AGENT TO A THIOL MOIETY IN A PROTEIN THAT CONTAINS AT LEAST ONE TRISULFIDE BOND

IPC classification:
C07K 1/113
Applicant:
Genentech, Inc.
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15832615

A METHOD FOR PROGNOSIS OF OVARIAN CANCER, PATIENT'S STRATIFICATION

IPC classification:
C07K 16/18, C12N 15/115, A61P 35/00, A61K 39/395, A61K 31/7088, G06F 19/18, G01N 33/50, C12Q 1/68
Applicant:
Agency for Science, Technology and Research
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15756216

DEPOLYMERISATION OF OXIDISED LIGNIN

IPC classification:
D21C 9/10, C07G 1/00, C07B 41/06, C07B 41/02
Applicant:
The University Court of the University of St. Andrews
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP15760045

ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19

IPC classification:
A61P 35/00, C07K 19/00, C07K 14/705, C07K 14/725, A61K 35/17, C07K 16/28
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP16196664

METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY

IPC classification:
A61K 45/06, A61P 43/00, A61K 33/00, A61K 31/00, A61K 31/7076
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15847907

METHODS FOR ASSESSING RISK OF DEVELOPING BREAST CANCER

IPC classification:
C40B 40/06, C12Q 1/68
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15782009

CYSTEINE LABELLING

IPC classification:
G01N 33/68, C12Q 1/48, C12Q 1/44
Applicant:
University of Dundee
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15778760

CONTAINER STRUCTURE WITH A BUILT-IN OPENING AND RECLOSING FEATURE

IPC classification:
B65D 77/20, B65D 75/58
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15784441

SELF-ASSEMBLING TRIPEPTIDES

IPC classification:
G06F 19/16, B82Y 40/00, C07K 5/087, C07K 5/09
Applicant:
University of Strathclyde
Agent:
George Schlich, Schlich LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15851315

METHODS FOR TREATING CARDIOVASCULAR DYSFUNCTION AND IMPROVING FLUID HOMEOSTASIS WITH A PEPTIDE HORMONE

IPC classification:
A61P 9/10, A61P 9/00, A61K 38/22, A61K 38/10, A61K 38/16
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15793955

METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY

IPC classification:
C07K 16/28
Agent:
Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15790186

BIOPROCESS FOR COPRODUCTION OF ETHANOL AND MYCOPROTEINS

IPC classification:
C12P 7/14, C12P 7/06, C12P 21/00
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP17150631

ANTIBODIES TO MUC16 AND METHODS OF USE THEREOF

IPC classification:
C07K 16/30, A61P 35/00, A61K 39/395, C12N 5/18, C12N 15/13, C07K 16/18
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The application has been published
EP15816318

METHODS AND COMPOSITIONS FOR ADOPTIVE CELL THERAPY

IPC classification:
C07K 16/28, C07K 14/725, C07K 14/705
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15866021

USE OF STRIATAL CONNECTIVITY PATTERNS FOR EVALUATING ANTIPSYCHOTIC AGENTS

IPC classification:
G01N 33/48
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15807983

LUMINESCENT PALLADIUM(0) AND PLATINUM(0) CARBENE COMPLEXES FOR OLEDS

IPC classification:
C09K 11/06, C07F 15/00, H01L 51/54
Applicant:
The University Court of the University of St. Andrews
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The patent has been granted
EP14908901

POLYMER FOAM SHEET AND BARRIER LAYER COMPOSITE

IPC classification:
B32B 27/20, E04F 15/18, C08J 9/35
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15820242

LIGHT EMITTING ELECTROCHEMICAL CELLS AND COMPOUNDS

IPC classification:
H01L 51/54, H01L 51/50
Applicant:
The University Court of the University of St. Andrews
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16703392

MODIFIED HEPATITIS POST-TRANSCRIPTIONAL REGULATORY ELEMENTS

IPC classification:
C12N 15/867, C12N 15/85
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16737836

CTLA4-BINDING PROTEIN PEPTIDE-LINKER MASKS

IPC classification:
A61K 38/00
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16739692

DIAGNOSTIC DEVICES AND METHODS FOR MITIGATING HOOK EFFECT AND USE THEREOF

IPC classification:
A61B 10/00, G01N 33/558, G01N 33/74, G01N 33/536, G01N 33/50, G01N 33/48
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16702793

USES OF CO-CRYSTALS

IPC classification:
A61Q 5/06, A61Q 5/10, A61K 8/49, C09B 67/22, C09B 67/48
Applicant:
University of Strathclyde
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15880432

ULTRASOUND LOCALIZATION OF OBSTRUCTION FOR OBSTRUCTIVE SLEEP APNEA

IPC classification:
A61B 8/08
Applicant:
University of Maryland Baltimore
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16702306

ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR ROR1

IPC classification:
A61K 39/395, C07K 16/28
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16702772

NO CONTAINING COMPOSITIONS

IPC classification:
B01J 20/22
Applicant:
The University Court of the University of St. Andrews
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16752918

METHODS OF MODULATING IMMUNE AND INFLAMMATORY RESPONSES VIA ADMINISTRATION OF AN ALGAL BIOMASS

IPC classification:
A61P 19/02, A61P 11/00, A61P 29/00, A61K 36/02, A61K 36/05
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16751815

IMPROVED DESCENDER

IPC classification:
B66D 3/04, B66D 3/02, A62B 1/18, A62B 1/08, A63B 29/02, A62B 1/14
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16756450

METHODS AND COMPOSITIONS FOR TREATING DYSTROGLYCANOPATHY DISORDERS

IPC classification:
A61P 21/00, A61K 38/17, C12P 21/02, C12N 5/10, C12N 15/861, C12N 15/12, C07K 14/47
Applicant:
The University of North Carolina at Chapel Hill
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP17187036

FORMATION, REPAIR AND MODIFICATION OF LAY UP TOOLS

IPC classification:
B05D 1/12, B29C 33/38, B29C 33/56, C22C 38/02, C22C 38/04, C22C 38/08, B05B 13/00, B21K 5/20, C23C 24/04, B21D 37/02, B29C 70/30
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The application has been published
EP16793387

METHODS FOR IDENTIFYING TARGETS FOR ANTIMICROBIAL AND ANTIPROLIFERATIVE COMPOUNDS AND COMPOSITIONS THEREFROM

IPC classification:
A61P 31/10, G01N 33/48, C12Q 1/18, C12N 15/10
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16795598

PLANT WITH INCREASED SILICON UPTAKE

IPC classification:
C12Q 1/68, C12N 5/10, C12N 5/04, C12N 15/29, C12N 15/113, C12N 1/02, C05D 9/00, A01P 21/00, A01N 59/00, A01N 3/00, A01K 1/00, A01H 5/00, A01H 1/04, C12N 15/82
Applicant:
Université Laval
Applicant:
Syngenta Participations AG
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16800635

APPARATUS AND METHOD FOR PLACEMENT OF DEVICE ALONG WALL OF A BODY LUMEN

IPC classification:
A61M 29/00
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP17184049

DETECTION DEVICES AND RELATED METHODS OF USE

IPC classification:
A61B 5/055
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
The application has been published
EP16728527

COMPOSITION AND METHODS FOR REGULATING INHIBITORY INTERACTIONS IN GENETICALLY ENGINEERED CELLS

IPC classification:
A61K 35/17, C12N 15/113, C12N 15/11
Agent:
Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16815111

METHOD AND APPARATUS FOR PROVIDING ECONOMICAL, PORTABLE DEFICIT-ADJUSTED ADAPTIVE ASSISTANCE DURING MOVEMENT PHASES OF AN IMPAIRED ANKLE

IPC classification:
A61H 3/00, A61B 5/103, B25J 9/16
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16812056

NOVEL THROMBIN INHIBITORS

IPC classification:
A61P 7/02, A61K 38/10, A61K 38/57, C07H 21/04, C07K 7/08, C07K 14/81
Applicant:
National University of Singapore
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16815379

TECHNIQUES FOR PRODUCING AN IMAGE OF RADIOACTIVE EMISSIONS USING A COMPTON CAMERA

IPC classification:
G01T 1/29, G01T 1/24, G01T 1/20, G01T 1/164, G01T 1/16, G01T 1/161
Applicant:
University of Maryland, Baltimore - Office of Research and Development
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16742568

ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY

IPC classification:
C12N 5/0783
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15820241

LIGHT EMITTING DEVICES AND COMPOUNDS

IPC classification:
H01L 33/00, C09K 11/06, C07D 417/10, C07D 413/10, C07F 9/572
Applicant:
The University Court of the University of St. Andrews
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16828378

METHODS OF TREATING CD166-EXPRESSING CANCER

IPC classification:
G01N 33/574, A61P 35/00, A61K 39/395, A61K 39/00
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16827746

POROUS SILICA AND DEODORANT CONTAINING SAME

IPC classification:
C01B 33/18, C01B 33/12, B01J 20/30, B01J 20/28, B01J 20/10, A61L 9/16, A61L 9/01, C01B 37/02
Applicant:
Toyo Seikan Group Holdings Ltd (Toyo Seikan Kaisha Ltd)
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16745138

INHIBITORY IMMUNOGLOBULINS

IPC classification:
G01N 33/569
Applicant:
University of Birmingham
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16833409

SEPARATING INNER SKIN FROMJATROPHA CURCAS

IPC classification:
C11B 1/04, A23K 10/37, A23K 10/30, A23L 25/00, A23L 5/20
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16762847

SILICA SYNTHESIS

IPC classification:
C01B 33/193
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16766061

NOVEL THERAPY

IPC classification:
A61K 31/565, A61K 38/22
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16775919

TUNABLE VARIANT IMMUNOGLOBULIN SUPERFAMILY DOMAINS AND ENGINEERED CELL THERAPY

IPC classification:
C07K 14/705
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16854367

MODULATING GAMMA - C -CYTOKINE ACTIVITY

IPC classification:
C12N 15/26, C12N 15/24, A61K 38/20, C07K 14/55, C07K 7/08
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made

Please Sign in to use this feature